Literature DB >> 2052135

The 5-HT1A receptor: an overview of recent advances.

S el Mestikawy1, A Fargin, J R Raymond, H Gozlan, M Hnatowich.   

Abstract

Progress in the field of neuronal receptor research has accelerated during the last few years due to developments in pharmacology and molecular biology. This is particularly true in the case of the serotonin 5-HT1A receptor. In 1983 the very selective, high affinity 5-HT1A agonist 8-OH-DPAT was developed which allowed the pharmacology and distribution of the 5-HT1A receptor in the central nervous system of the rat and man to be extensively characterized. By 1987, the gene encoding this receptor protein was cloned and sequenced, allowing not only elucidation of its structure, but also better insight into the nature of its coupling to transmembrane signal transduction systems. Thus in a short period of time considerable knowledge has accumulated on how serotonin exerts its functions in the central nervous system via the 5-HT1A receptor. In the present review we will briefly discuss some of the latest developments regarding the 5-HT1A receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052135     DOI: 10.1007/bf00965820

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  66 in total

1.  Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin.

Authors:  R A Dixon; B K Kobilka; D J Strader; J L Benovic; H G Dohlman; T Frielle; M A Bolanowski; C D Bennett; E Rands; R E Diehl; R A Mumford; E E Slater; I S Sigal; M G Caron; R J Lefkowitz; C D Strader
Journal:  Nature       Date:  1986 May 1-7       Impact factor: 49.962

2.  cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor.

Authors:  B K Kobilka; R A Dixon; T Frielle; H G Dohlman; M A Bolanowski; I S Sigal; T L Yang-Feng; U Francke; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

3.  [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.

Authors:  K Herrick-Davis; M Titeler
Journal:  J Neurochem       Date:  1988-02       Impact factor: 5.372

4.  Two 5-HT receptors linked to adenylate cyclase in guinea pig hippocampus are discriminated by 5-carboxamidotryptamine and spiperone.

Authors:  A Shenker; S Maayani; H Weinstein; J P Green
Journal:  Eur J Pharmacol       Date:  1985-03-12       Impact factor: 4.432

5.  Short-term regulation of Na+/K+ adenosine triphosphatase by recombinant human serotonin 5-HT1A receptor expressed in HeLa cells.

Authors:  J P Middleton; J R Raymond; A R Whorton; V W Dennis
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.

Authors:  A Dumuis; R Bouhelal; M Sebben; R Cory; J Bockaert
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

7.  The human 5-HT1A receptor expressed in HeLa cells stimulates sodium-dependent phosphate uptake via protein kinase C.

Authors:  J R Raymond; A Fargin; J P Middleton; J M Graff; D M Haupt; M G Caron; R J Lefkowitz; V W Dennis
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

8.  Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin.

Authors:  M H Makman; B Dvorkin; S M Crain
Journal:  Brain Res       Date:  1988-04-05       Impact factor: 3.252

9.  Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists.

Authors:  J S Sprouse; G K Aghajanian
Journal:  Synapse       Date:  1987       Impact factor: 2.562

10.  Pharmacological and biochemical characterization of rat hippocampal 5-hydroxytryptamine1A receptors solubilized by 3-[3-(cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS).

Authors:  S el Mestikawy; C Cognard; H Gozlan; M Hamon
Journal:  J Neurochem       Date:  1988-10       Impact factor: 5.372

View more
  6 in total

1.  [3H]-5-carboxamidotryptamine labels 5-HT1D binding sites in bovine substantia nigra.

Authors:  H P Nowak; C D Mahle; F D Yocca
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

2.  8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding sites in goldfish retina.

Authors:  L Lima; C Schmeer; M Urbina
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

Review 3.  Neurally mediated syncope and serotonin reuptake inhibitors.

Authors:  D Samoil; B P Grubb
Journal:  Clin Auton Res       Date:  1995-10       Impact factor: 4.435

4.  Activation of somatodendritic 5-HT1A autoreceptors reduces the acquisition and expression of cued fear in the rat fear-potentiated startle test.

Authors:  Yulong Zhao; Elisabeth Y Bijlsma; Freija Ter Heegde; Monika P Verdouw; J Garssen; Adrian Newman-Tancredi; Lucianne Groenink
Journal:  Psychopharmacology (Berl)       Date:  2018-12-12       Impact factor: 4.530

Review 5.  Medicinal Cannabis and Central Nervous System Disorders.

Authors:  Yuma T Ortiz; Lance R McMahon; Jenny L Wilkerson
Journal:  Front Pharmacol       Date:  2022-04-21       Impact factor: 5.988

6.  Human serotonin receptor 5-HT(1A) preferentially segregates to the liquid disordered phase in synthetic lipid bilayers.

Authors:  M Gertrude Gutierrez; Noah Malmstadt
Journal:  J Am Chem Soc       Date:  2014-09-19       Impact factor: 15.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.